SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-761641
Filing Date
2016-11-07
Accepted
2016-11-07 16:05:58
Documents
4
Period of Report
2016-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d277358d8k.htm 8-K 15098
2 EX-99.1 d277358dex991.htm EX-99.1 44854
3 GRAPHIC g277358ex991p01.jpg GRAPHIC 14245
4 GRAPHIC g277358ex991p02.jpg GRAPHIC 12325
  Complete submission text file 0001193125-16-761641.txt   97944
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 161978125
SIC: 2834 Pharmaceutical Preparations